S. Wade Kimmell, OD
Advertisement
Articles by S. Wade Kimmell, OD
Employ treatment strategies that control both conditions with less reliance on drops.
Advertisement
Latest Updated Articles
Your glaucoma patients also have ocular surface diseaseJanuary 29th 2020
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
2
Brepocitinib for noninfectious uveitis meets all phase 3 trial end points
3
More than monitoring: Using AMD visits to promote healthy vision aging
4
The Independent Advantage S02 E07: Is your front desk missing opportunities?
5